Breast Cancer Awareness MonthMain MenuIntroductionA Timeline on Breast Cancer Discovery and TreatmenteBooks & JournalsContaining eBooks on the history, treatment, and guidance on Breast CancerOnline ResourcesDavid Carson723ce044ababd187a4457b00bec1d6bce0365855Ivan Portillo741ad6f42573dbb784db9511d4627772eb86aa19
1998: Trastuzumab (Herceptin)
1media/Trastuzumab_Fab-HER2_complex_1N8Z_thumb.png2023-09-21T22:09:36+00:00Ivan Portillo741ad6f42573dbb784db9511d4627772eb86aa193161Trastuzumab (Herceptin), a monoclonal antibody that targets abnormal genes in breast cancer cells, was approved in 1998 by the FDA. Image Attribution: Fvasconcellos , Public domain, via Wikimedia Commonsplain2023-09-21T22:09:36+00:001998Ivan Portillo741ad6f42573dbb784db9511d4627772eb86aa19
This page has tags:
1media/Hippocrates.jpg2023-09-20T21:35:02+00:00Ivan Portillo741ad6f42573dbb784db9511d4627772eb86aa19A Timeline on Breast Cancer Discovery and TreatmentIvan Portillo85timeline2023-09-25T23:21:48+00:003000BCE400BCE1700 - 179917401840 - 184918661882189719481940 - 194919531960 - 196919711970 - 19791990 - 19991998200620182022Ivan Portillo741ad6f42573dbb784db9511d4627772eb86aa19